For example, the SELECT trial demonstrated that semaglutide reduced major cardiovascular events by 20% in overweight patients
Both formulations are approved for people with obesity (BMI greater than 30) or excess weight (BMI greater than 27) who also have at least one other weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Chief Critic Cubans company has been criticized for offering a limited number of name-brand drugs and only providing some generic drugs
proposed that in the initiation of HF, myocardial fatty acid, glucose, ketone body, and branched-chain amino acid metabolism is disturbed, leading to alterations in myocardial structure and function 26,40
The Bottom Line BPC-157 sits at a complicated intersection of science, personal experience, and public opinion
Take-Home Message Fatty liver disease has emerged as a silent but prevalent health challenge